MAGE-A4-TCRS

Patent europeic · EP3946621 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3946621
Numer da la dumonda
EP20719942
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-03-2020
Publitgà
09-02-2022
Concedì
21-05-2025
La protecziun finescha il pli tard
26-03-2040
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61P 35/00 (2006.01)
C07K 14/47 (2006.01)
C07K 14/725 (2006.01)
A61K 38/00 (2006.01)
Prioritad
EP 19165387 27.03.2019
Dumonda PCT
PCT/EP2020/058779 27.03.2020
Publicaziun PCT
WO2020/193767 01.10.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-04-2026

    Midada

    Published in Swissreg on 02.04.2026

  2. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  3. 13-08-2025

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 13.08.2025

  4. 21-05-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.05.2025

Partidas

Possessur

Medigene Immunotherapies GmbH

Lochhamer Straße 11, 82152 Planegg-Martinsried, DE

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road, Tarrytown, NY 10591, US

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

ELLINGER, Christian

80337 Munich, DE

SOMMERMEYER, Daniel

80638 Munich, DE

BLACKBURN PARSONS, Geoffrey

Jamaica Plain, Massachusetts 02130, US

MANN, Jasdeep

Lake Forest Park, Washington 98155, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.